Fingerprint
Dive into the research topics of 'Impact of her2 heterogeneity on treatment response of early-stage her2-positive breast cancer: Phase ii neoadjuvant clinical trial of t-dm1 combined with pertuzumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically